Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 and up

Using vancomycin powder to prevent infections in spine surgery

Official title: The Effect of Intrawound Vancomycin Powder in Spine Surgery: A Prospective Randomized Controlled Trial

Run by Windsor-Essex Compassionate Care Community · NCT04825522 · Data updated 2026-11-12

This study is testing if using vancomycin powder during spine surgery can help prevent infections after the operation compared to standard care.

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1643 (estimated)
SponsorWindsor-Essex Compassionate Care Community
Academic / other
Locations2 sites (Windsor, Ontario and 1 other locations)
StatusRecruiting
StartedMarch 27, 2022
Main results expectedDecember 1, 2028
Study endsDecember 1, 2028
Registry record updatedApril 23, 2024
Trial IDNCT04825522 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults requiring surgery for any spine disease.

Probably not a fit

Patients with a history of infections at the surgical site or those allergic to vancomycin will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of intrawound vancomycin powder in reducing postoperative wound infections in patients undergoing spine surgery. Participants will be randomly assigned to receive either the vancomycin intervention or standard care without it, while both the patients and the surgeons will remain blinded to the treatment allocation. Data on patient demographics, comorbidities, and surgical details will be collected, and the incidence of infections will be monitored for 12 weeks post-surgery. The goal is to determine if local vancomycin application can significantly lower the rates of surgical site infections compared to standard practices.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of postoperative infections, leading to improved patient outcomes and lower healthcare costs.

How similar studies have gone: Previous studies have shown mixed results regarding the effectiveness of intrawound vancomycin, making this investigation both relevant and necessary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients requiring surgery due to any spine disease.

Exclusion Criteria:

* A previous history of infections at the spine surgical site.
* Biopsy procedure.
* Patients with a postoperative follow-up time of less than 12 weeks.
* Patients allergic to vancomycin.
* Patient is less than 18 years old.

Where it's running

  • Windsor Regional Hospital - Ouellette
    Windsor, Ontario, Canada
    Recruiting
  • Cairo University Hospitals
    Cairo, Egypt
    Recruiting

Study contacts

  • Principal investigator: Mohamed Soliman, MD — Western University
  • Study coordinator: Mohamed Soliman, MSc, MD
  • Email: msolim8@uwo.ca
  • Phone: 17329241637

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.